Indevus Pharmaceuticals, Inc.
Company's FY2003 highlighted by preparation for launch of trospium in 2004
Published in Medical Device Business Week, January 12th, 2004
The company reported a consolidated net loss of $31,812,000, or $0.68 per share (basic), for fiscal 2003, compared to a consolidated net loss of $17,586,000, or $0.38 per share (basic), for fiscal 2002. For the 3-month period ended September 30, 2003, the company reported a consolidated net loss of $11,365,000, or $0.24 per share (basic), compared to a consolidated net loss of $4,817,000, or $0.10 per share (basic), for the 3-month period ended September 30, 2002.
The increased net loss for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Akers Biosciences, Inc.
Biotech company announces cancellation of shares - Enzo Biochem, Inc.
Gene identification company reports 73.7% gross profit margin - M.D. Anderson Cancer Center
IIp45 antagonizes IGFBP-2 stimulation of glioma cell invasion - M.D. Anderson Cancer Center
PI3-K pathway may be major pathway for trastuzumab-mediated radiosensitization - M.D. Anderson Cancer Center
p27(KIP1) has a novel role in down-regulation of telomerase activity - Manchester Royal Eye Hospital
HSV keratitis can occur in keratoplasty as host reactivation, donor transmission - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
